Biocept Inc. Financial Flexibility Index
Biocept Inc. financial flexibility index. Biocept Inc. (BIOCQ) has a Financial Flexibility Index of -0.14x as of June 2023. Free cash flow of $-2.99 Million (operating CF $-3.09 Million minus capex $97.00K) represents 0% of total liabilities ($21.81 Million). See BIOCQ cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Biocept Inc. (2019–2022)
Financial flexibility index of Biocept Inc. from 2019 to 2022. Historical Financial Flexibility Index trend for Biocept Inc. across 4 annual periods. Explore Biocept Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Biocept Inc. Financial Flexibility Index by Year (2019–2022)
Biocept Inc. financial flexibility index by year from 2019 to 2022. Year-by-year free cash flow to debt coverage for Biocept Inc.. For the full cash flow conversion analysis, see BIOCQ operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | -0.57x | $-12.48 Million | $-13.29 Million | $22.01 Million | ▼ -347.2% |
| 2021 | 0.23x | $5.26 Million | $3.69 Million | $22.94 Million | ▲ +128.8% |
| 2020 | -0.80x | $-18.92 Million | $-19.79 Million | $23.76 Million | ▲ +76.7% |
| 2019 | -3.42x | $-22.31 Million | $-23.05 Million | $6.53 Million | — |